GNS Healthcare, Brigham and Women's Ink Two-Year Partnership to Create Predictive Models for Asthma

The partners plan to use GNS’ REFS platform to develop a predictive model that connects genetics to clinical outcomes in asthma. The findings could be useful for pharma companies looking to develop new therapies for the disease.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.